Tower Semiconductor (TSEM) PT Raised to $20 at Needham & Company Following Q2 Results; Top Rating Maintained
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Drexel Hamilton Reiterates Buy on Tower Semiconductor (TSEM) Following Positive 2Q Report
August 5, 2016 7:01 AM EDTDrexel Hamilton reiterated a Buy rating and $28.00 price target on Tower Semiconductor (NASDAQ: TSEM) following the company's 2Q earnings report. Sales grew 10% sequentially and 29% year-over-year. Adjusted EPS was $0.39, vs the consensus of $0.35. Q3 guidance is for another 6.5% of sequential growth to a mid-point of $325... More
TowerJazz (TSEM) Tops Q2 EPS by 10c; Offers Q3 Outlook
August 4, 2016 6:20 AM EDTTowerJazz (NASDAQ: TSEM) reported Q2 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $305 million versus the consensus estimate of $300 million.
TowerJazz expects revenues for the third quarter of 2016 ending September 30, 2016 to be $325 million, with an upward or downward... More
